Platelet-activating factor antagonists: scientific background and possible clinical applications.
Koltai
M
M
Institut Henri Beaufour, Le Plessis Robinson, France.
Guinot
P
P
Hosford
D
D
Braquet
P G
PG
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002545:Brain Ischemia / Q000188:drug therapy; D016084:Bronchoconstriction / Q000187:drug effects; D006801:Humans; D007249:Inflammation / Q000378:metabolism; D008070:Lipopolysaccharides / Q000633:toxicity; D017202:Myocardial Ischemia / Q000188:drug therapy; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors* / Q000502:physiology; D010980:Platelet Membrane Glycoproteins / Q000032:analysis / Q000037:antagonists & inhibitors; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; D012772:Shock, Septic / Q000628:therapy
D000911:Antibodies, Monoclonal; D008070:Lipopolysaccharides; D010972:Platelet Activating Factor; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; C039351:platelet activating factor receptor